Filing Flows

Filing Flows › Comparisons › ABBV vs AZN

AbbVie vs AstraZeneca: ABBV and AZN compared

AbbVie is the larger company: $17.4B of revenue in its latest quarter (Q3 2026) against $16.2B for AstraZeneca (Q3 2026). AbbVie is growing faster (+10% against +7% a year earlier). AbbVie is more profitable, with an operating margin of 36.0% against 27.1%.

AbbVie vs AstraZeneca, latest quarterAbbVie vs AstraZeneca, latest quarterAbbVie (ABBV)AstraZeneca (AZN)Revenue$17.4B$16.2BRevenue growth, Y/Y+10%+7%Operating margin36.0%27.1%Net margin24.2%19.2%Free cash flow$7.3B$5.1B

Where the money goes: ABBV and AZN

AbbVie (ABBV) · Q3 2026

AbbVie, Q3 2026: revenue $17.4B (+10% year over year), operating margin 36.0%, net earnings $4.2B, operating cash flow $7.6B. The chart follows the revenue to costs, profit and cash.

AstraZeneca (AZN) · Q3 2026

AstraZeneca, Q3 2026: revenue $16.2B (+7% year over year), operating margin 27.1%, net earnings $3.1B, operating cash flow $5.8B. The chart follows the revenue to costs, profit and cash.

AstraZeneca revenue by segment, Q3 2026AstraZeneca revenue by segment, Q3 2026Oncology$7.1BCVRM$2.6BFarxiga$1.6BUltomiris$1.4B
AbbVie (ABBV)AstraZeneca (AZN)
Latest quarterQ3 2026Q3 2026
Revenue$17.4B$16.2B
Revenue growth, Y/Y+10%+7%
Gross margin—81.8%
Operating margin36.0%27.1%
Net earnings$4.2B$3.1B
Net margin24.2%19.2%
Operating cash flow$7.6B$5.8B
Free cash flow$7.3B$5.1B
Market value$516.2B—
P/E50.1×—
Analysts’ mean target$310.65—

Where the revenue comes from

AstraZeneca

Questions

Which is bigger, AbbVie or AstraZeneca?

AbbVie is the larger company: $17.4B of revenue in its latest quarter (Q3 2026) against $16.2B for AstraZeneca (Q3 2026).

Is AbbVie or AstraZeneca growing faster?

AbbVie is growing faster (+10% against +7% a year earlier).

Which is more profitable, AbbVie or AstraZeneca?

AbbVie is more profitable, with an operating margin of 36.0% against 27.1%.

More: AbbVie earnings · how AbbVie makes money · AstraZeneca earnings · how AstraZeneca makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 6-K filed Oct 30, 2026). Fiscal quarters can end on different dates. Not investment advice.